-0.01 | -3.95%
| Price and Volume | |
|---|---|
| Recent Price | 0.27 |
| 52 Week High | 3.70 |
| 52 Week Low | 0.25 |
| Avg. Daily Vol. (Mil) | 0.24 |
| Beta (3 year) | 2.58 |
| Share Related Items | |
| Mkt Cap (Mil) | 21.14 |
| Shares Out (Mil) | 78.04 |
| Float (Mil) | 39.24 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.40 |
| Current Ratio | 0.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.48 |
| Price/Book | 0.00 |
| Price/Cash Flow | -0.80 |
| Per Share Data | |
| Earnings | -0.52 |
| Sales | 0.56 |
| Book Value | 0.00 |
| Cash Flow | -0.32 |
| Business Summary | |
|---|---|
| Stereotaxis, Inc. designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. | |
| General Information | |
| 4320 Forest Park Avenue
Suite 100 St. Louis, MO 63108 |
|
| www.stereotaxis.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 171 | |
| CEO: Michael P. Kaminski | |
| Short Interest | |
| Current Month (Mil) | 4.80 |
| Previous Month (Mil) | 5.91 |
| Short Interest Ratio (Days) | 16.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -76.90 |
| Return on Investments | 265.00 |
| Profitability | |
| Gross Margin | 77.30 |
| EBIT Margin | -54.80 |
| Profit Margin | -64.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,447.49 | 1,314.11 | 2,839.29 | 16.27 |
Oil *
103.44
|
|
DOWN
133.20 |
DOWN
18.31 |
DOWN
31.70 |
DOWN
1.04 |
10 Yr
1.63%
SPDR Gold
151.82
|
|
-1.06%
|
-1.37%
|
-1.10%
|
-6.01%
|
Data delayed 20 minutes |
Connect with TheStreet